Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 28 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor				Phase III				SJCRH-SJMB03 NCT00085202
	Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors				Phase III				CHLA-HEAD-START-III CHLA-HSIII, CHLA-2004-020, CHLA-04.020, NCT00392886, UMN-MT2004-06
	A Phase I/II Study of the Photon Radiosurgery System				Phase II, Phase I				CNS 0201 NCT00179907
	Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors				Phase II, Phase I				R01 CA 89395-01 Topotecan, Brain Tumors, Intracerebral Clysis, NCT00452959
	A Multi-Center Phase I Study of AP23573 in Pediatric Patients With Advanced Solid Tumors				Phase II, Phase I				SUN08-01 NCT00704054
	Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors				Phase II, Phase I				CHNMC-07053 07053, CA180 121, NCT00788125
	Antineoplaston Therapy in Treating Children With Brain Tumors				Phase II				BC-BT-10 NCT00003458
	Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors				Phase II				BC-BT-22 NCT00003476
	Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma				Phase II				MGH-99-271 NCT00105560
	Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer				Phase II				MSKCC-05122 NCT00445965


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute